GlaxoSmithKline S.A.E (EGX: BIOC)

Market Cap	3.25B
Revenue (ttm)	2.81B
Net Income (ttm)	119.55M
Shares Out	83.51M
EPS (ttm)	1.43
PE Ratio	27.20
Forward PE	n/a
Dividend	0.75 (1.93%)
Ex-Dividend Date	Jul 18, 2024

Volume	104,656
Average Volume	106,730
Open	39.84
Previous Close	39.84
Day's Range	39.20 - 40.97
52-Week Range	24.70 - 47.50
Beta	1.04
RSI	50.39
Earnings Date	Mar 3, 2025

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E. was founded in 1981 and is headquartered in London, the United Kingdom. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2023, GlaxoSmithKline S.A.E's revenue was 2.24 billion, an increase of 22.87% compared to the previous year's 1.82 billion. Earnings were 60.46 million, a decrease of -91.78%.